TRAJ20 and cancer: Of the remaining cancer-activated MR1-restricted TCRs, some used the MAIT cell–preferred TRAJ20 and TRAJ12 to generate a similarly placed tyrosine and others used TRAJ26, TRAJ47, or TRAJ32 to encode this tyrosine residue (Figure 4A).